BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16749407)

  • 1. An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension.
    Chen X; Zheng F; Chen P; Tang L; Wei R; Yu Y; Su Y; Kikkawa T; Yamamoto M
    J Int Med Res; 2006; 34(2):121-8. PubMed ID: 16749407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH; Oparil S; Feng Z
    Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension in the very old.
    Otterstad JE; Ruilope LM
    Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group.
    Hart W; Holwerda NJ
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):637-43. PubMed ID: 9493701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo.
    Kuschnir E; Acuña E; Sevilla D; Vasquez J; Bendersky M; Resk J; Glazer R
    Clin Ther; 1996; 18(6):1213-24. PubMed ID: 9001838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group.
    Frishman WH; RAM CV; McMahon FG; Chrysant SG; Graff A; Kupiec JW; Hsu H
    J Clin Pharmacol; 1995 Nov; 35(11):1060-6. PubMed ID: 8626878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study.
    Naber FB; Häge R; Mortelmans J
    Int J Clin Pract Suppl; 2000 Nov; (114):27-35. PubMed ID: 11221292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
    Lins R; Haerden Y; de Vries C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of benazepril plus hydrochlorothiazide versus benazepril alone in hypertensive patients unresponsive to benazepril monotherapy.
    Holwerda K; Hoogma RP; Oldenbroek C; Huige RC; Wester A; Rijnierse JM
    Clin Ther; 1994; 16(6):942-51. PubMed ID: 7697691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term efficacy and safety profile of barnidipine.
    Smilde JG
    Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
    Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension.
    Chen T; Chen GH; Yang TS; Zhong ZY; An WS; Zhang XX; Li JD
    Chin Med J (Engl); 2013 Jun; 126(12):2286-90. PubMed ID: 23786940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial.
    Yan P; Fan W;
    Clin Exp Hypertens; 2014; 36(4):268-74. PubMed ID: 23859303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barnidipine real-life tolerability in arterial hypertension: results from the BASIC-HT study.
    Lins R; Marckx P; Vandebeek R; Vanhoutvinck C; Neuville O
    Acta Clin Belg; 2015 Aug; 70(4):244-50. PubMed ID: 25816195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.